202 related articles for article (PubMed ID: 12505141)
1. Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone.
Green AI; Burgess ES; Dawson R; Zimmet SV; Strous RD
Schizophr Res; 2003 Mar; 60(1):81-5. PubMed ID: 12505141
[TBL] [Abstract][Full Text] [Related]
2. Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia.
Kim JH; Kim D; Marder SR
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):984-8. PubMed ID: 18262321
[TBL] [Abstract][Full Text] [Related]
3. The effect of clozapine and risperidone on attentional bias in patients with schizophrenia and a cannabis use disorder: An fMRI study.
Machielsen MW; Veltman DJ; van den Brink W; de Haan L
J Psychopharmacol; 2014 Jul; 28(7):633-42. PubMed ID: 24646809
[TBL] [Abstract][Full Text] [Related]
4. Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study.
Machielsen MWJ; Veltman DJ; van den Brink W; de Haan L
Schizophr Res; 2018 Apr; 194():32-38. PubMed ID: 28351544
[TBL] [Abstract][Full Text] [Related]
5. Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review.
Arranz B; Garriga M; García-Rizo C; San L
Eur Neuropsychopharmacol; 2018 Feb; 28(2):227-242. PubMed ID: 29273271
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes.
Sevy S; Robinson DG; Sunday S; Napolitano B; Miller R; McCormack J; Kane J
Psychiatry Res; 2011 Aug; 188(3):310-4. PubMed ID: 21636134
[TBL] [Abstract][Full Text] [Related]
7. Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine.
Machielsen M; Beduin AS; Dekker N; ; Kahn RS; Linszen DH; van Os J; Wiersma D; Bruggeman R; Cahn W; de Haan L; Krabbendam L; Myin-Germeys I
J Psychopharmacol; 2012 Jan; 26(1):189-95. PubMed ID: 21768161
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
Volavka J; Nolan KA; Kline L; Czobor P; Citrome L; Sheitman B; Lindenmayer JP; McEvoy J; Lieberman JA
Schizophr Res; 2005 Jul; 76(1):127-9. PubMed ID: 15927808
[No Abstract] [Full Text] [Related]
9. Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients.
Scheltema Beduin AA; Swets M; Machielsen M; Korver N;
J Clin Psychiatry; 2012 Nov; 73(11):1395-402. PubMed ID: 23218156
[TBL] [Abstract][Full Text] [Related]
10. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
[TBL] [Abstract][Full Text] [Related]
11. Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.
Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M
J Clin Psychiatry; 2004 Apr; 65(4):551-6. PubMed ID: 15119920
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of clozapine vs. risperidone in treatment-naïve first-episode schizophrenia: results after one year.
Sanz-Fuentenebro J; Taboada D; Palomo T; Aragües M; Ovejero S; Del Alamo C; Molina V
Schizophr Res; 2013 Sep; 149(1-3):156-61. PubMed ID: 23870807
[TBL] [Abstract][Full Text] [Related]
13. An open comparison of clozapine and risperidone in treatment-resistant schizophrenia.
Flynn SW; MacEwan GW; Altman S; Kopala LC; Fredrikson DH; Smith GN; Honer WG
Pharmacopsychiatry; 1998 Jan; 31(1):25-9. PubMed ID: 9524981
[TBL] [Abstract][Full Text] [Related]
14. Comparison of time to rehospitalization among schizophrenic patients discharged on typical antipsychotics, clozapine or risperidone.
Lin CH; Lin SC; Chen MC; Wang SY
J Chin Med Assoc; 2006 Jun; 69(6):264-9. PubMed ID: 16863012
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study.
Kelly DL; McMahon RP; Liu F; Love RC; Wehring HJ; Shim JC; Warren KR; Conley RR
J Clin Psychiatry; 2010 Mar; 71(3):304-11. PubMed ID: 20079332
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of risperidone and clozapine in the treatment of patients with refractory schizophrenia or schizoaffective disorder: a retrospective analysis.
Sharif ZA; Raza A; Ratakonda SS
J Clin Psychiatry; 2000 Jul; 61(7):498-504. PubMed ID: 10937608
[TBL] [Abstract][Full Text] [Related]
17. Schizophrenic patients treated with clozapine or olanzapine perform better on theory of mind tasks than those treated with risperidone or typical antipsychotic medications.
Savina I; Beninger RJ
Schizophr Res; 2007 Aug; 94(1-3):128-38. PubMed ID: 17560766
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: a case report and review.
Lerma-Carrillo I; Molina JD; Cuevas-Durán T; González-Parra S; Blasco-Fontecilla H; Andrade-Rosa C; López-Muñoz F; Alamo C
Clin Neuropharmacol; 2007; 30(2):114-21. PubMed ID: 17414944
[TBL] [Abstract][Full Text] [Related]
19. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.
Anil Yağcioğlu AE; Kivircik Akdede BB; Turgut TI; Tümüklü M; Yazici MK; Alptekin K; Ertuğrul A; Jayathilake K; Göğüş A; Tunca Z; Meltzer HY
J Clin Psychiatry; 2005 Jan; 66(1):63-72. PubMed ID: 15669890
[TBL] [Abstract][Full Text] [Related]
20. Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone.
Hendouei N; Farnia S; Mohseni F; Salehi A; Bagheri M; Shadfar F; Barzegar F; Hoseini SD; Charati JY; Shaki F
Biomed Pharmacother; 2018 Jul; 103():965-972. PubMed ID: 29710513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
